AVE vs VIT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

53MEDIUM

VIT

VITURA FPO [VIT]

49LOW

Score Breakdown

AVE VIT
Technical
52
53
Catalyst
62
51
Sentiment
50
50
Fundamental
49
76
Momentum
75
28
Risk Gate
45
45

Key Metrics

AVE Metric VIT
$77.3MMarket Cap$18.6M
24.9MAvg Volume (20d)682K
N/AShort InterestN/A
$0.02752-Week High$0.075
$0.00452-Week Low$0.021
-2.4%Daily Change+3.6%
$0.020Reference Price$0.029
-182.9%ROE+1.2%
N/AProfit Margin+0.6%

Active Signals

AVE Signals

●MACD momentum is losing steam
●Beating the Small Ords index — relative strength of 1.65, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Very high P/S ratio (62.4x)
●Revenue in sharp decline (-17%)
●Small-cap ($20-100M)
●Not enough chatter to gauge sentiment — defaulting to neutral

VIT Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.1x)
●Moderate revenue growth (+8%)
●Near 52-week low (13% of range)
●Micro-cap ($5-20M) - high risk

Ask Scout AI to compare AVE and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AVH vs BIT →AVH vs COV →AVH vs CYC →AVH vs GSS →AVH vs HMD →
AVE Full Analysis → VIT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).